BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peng Q, Chen B, Wang H, Zhu Y, Wu J, Luo Y, Zuo G, Luo J, Zhou L, Shi Q, Weng Y, Huang A, He TC, Fan J. Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes. Aging (Albany NY) 2019;11:11520-40. [PMID: 31831718 DOI: 10.18632/aging.102552] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Mu W, Song Y, Yang L, Qian S, Yang Q, Liu Y, Tang Q, Tang Y. Bone morphogenetic protein 4 in perivascular adipose tissue ameliorates hypertension through regulation of angiotensinogen. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1038176] [Reference Citation Analysis]
2 Zhang L, Luo W, Liu J, Xu M, Peng Q, Zou W, You J, Shu Y, Zhao P, Wagstaff W, Zhao G, Qin K, Haydon RC, Luu HH, Reid RR, Bi Y, Zhao T, He T, Fu Z. Modeling lung diseases using reversibly immortalized mouse pulmonary alveolar type 2 cells (imPAC2). Cell Biosci 2022;12:159. [DOI: 10.1186/s13578-022-00894-4] [Reference Citation Analysis]
3 Ogbole OO, Ajayi TA, Odeku OA. Herbs and Plants Used for the Management and Treatment of Hepatitis Infections. Herbal Drugs for the Management of Infectious Diseases 2022. [DOI: 10.1002/9781119818779.ch14] [Reference Citation Analysis]
4 Baboota RK, Rawshani A, Bonnet L, Li X, Yang H, Mardinoglu A, Tchkonia T, Kirkland JL, Hoffmann A, Dietrich A, Boucher J, Blüher M, Smith U. BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH. Nat Metab 2022;4:1007-21. [PMID: 35995996 DOI: 10.1038/s42255-022-00620-x] [Reference Citation Analysis]
5 Cook JJ, Wei M, Segovia B, Cosio-Lima L, Simpson J, Taylor S, Koh Y, Kim S, Lee Y. Endurance exercise-mediated metabolic reshuffle attenuates high-caloric diet-induced non-alcoholic fatty liver disease. Ann Hepatol 2022;27:100709. [PMID: 35489641 DOI: 10.1016/j.aohep.2022.100709] [Reference Citation Analysis]
6 Marañón P, Fernández-García CE, Isaza SC, Rey E, Gallego-Durán R, Montero-Vallejo R, de Cía JR, Ampuero J, Romero-Gómez M, García-Monzón C, González-Rodríguez Á. Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool. Biomark Res 2022;10:35. [PMID: 35614516 DOI: 10.1186/s40364-022-00383-3] [Reference Citation Analysis]
7 Wang X, Ma B, Wen X, You H, Sheng C, Bu L, Qu S. Bone morphogenetic protein 4 alleviates nonalcoholic steatohepatitis by inhibiting hepatic ferroptosis. Cell Death Discov 2022;8:234. [PMID: 35477568 DOI: 10.1038/s41420-022-01011-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Marañón P, Fernández-garcía CE, Isaza SC, Rey E, Gallego-durán R, Montero-vallejo R, Rodríguez de Cía J, Ampuero J, Romero-gómez M, García-monzón C, González-rodríguez Á. Bone morphogenetic protein 2 is a new molecular target linked to nonalcoholic fatty liver disease with potential value as non-invasive screening tool.. [DOI: 10.1101/2022.03.17.22272494] [Reference Citation Analysis]
9 Gou Y, Weng Y, Chen Q, Wu J, Wang H, Zhong J, Bi Y, Cao D, Zhao P, Dong X, Guo M, Wagstaff W, Hendren‐santiago B, Chen C, Youssef A, Haydon RC, Luu HH, Reid RR, Shen L, He T, Fan J. Carboxymethyl chitosan prolongs adenovirus‐mediated expression of IL ‐10 and ameliorates hepatic fibrosis in a mouse model. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10306] [Reference Citation Analysis]
10 Zhong J, Wang H, Yang K, Wang H, Duan C, Ni N, An L, Luo Y, Zhao P, Gou Y, Sheng S, Shi D, Chen C, Wagstaff W, Hendren-Santiago B, Haydon RC, Luu HH, Reid RR, Ho SH, Ameer GA, Shen L, He TC, Fan J. Reversibly immortalized keratinocytes (iKera) facilitate re-epithelization and skin wound healing: Potential applications in cell-based skin tissue engineering. Bioact Mater 2022;9:523-40. [PMID: 34820586 DOI: 10.1016/j.bioactmat.2021.07.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Gough NR, Xiang X, Mishra L. TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer. Gastroenterology 2021;161:434-452.e15. [PMID: 33940008 DOI: 10.1053/j.gastro.2021.04.064] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
12 Zhang Z, Wen H, Peng B, Weng J, Zeng F. HFD-induced TRAF6 upregulation promotes liver cholesterol accumulation and fatty liver development via EZH2-mediated miR-429/PPARα axis. Mol Ther Nucleic Acids 2021;24:711-27. [PMID: 33996254 DOI: 10.1016/j.omtn.2021.01.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 An L, Shi Q, Zhu Y, Wang H, Peng Q, Wu J, Cheng Y, Zhang W, Yi Y, Bao Z, Zhang H, Luo Y, Fan J. Bone morphogenetic protein 4 (BMP4) promotes hepatic glycogen accumulation and reduces glucose level in hepatocytes through mTORC2 signaling pathway. Genes Dis 2021;8:531-44. [PMID: 34179315 DOI: 10.1016/j.gendis.2020.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Yang S, Dai H, Hu W, Geng S, Li L, Li X, Liu H, Liu D, Li K, Yang G, Yang M. Association between circulating follistatin-like-1 and metabolic syndrome in middle-aged and old population: A cross-sectional study. Diabetes Metab Res Rev 2021;37:e3373. [PMID: 32592413 DOI: 10.1002/dmrr.3373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]